Evidence map›Paper›PMID 42273748›Full record

ArticleBiology open2026

Perspectives from the 2024 School on Neuropharmacology Research and Drug Development in Harare, Zimbabwe: insights from participants.

John Senanu, Bertrand Yuwong Wanyu, Jessica Burns, Victor Bassey Archibong, Rosa M Chinheya, Nji S Ombel Musa, Shingirayi Zengeni, Asmaa Haj-Khlifa, Kehinde Oluwaseyi Adeniji, Rhoda Mama Kolo and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

John SenanuDepartment of Biochemistry, University of Cape Coast, P. O. Box 426, Cape Coast, Ghana.ORCID 0000-0003-0319-2645
Bertrand Yuwong WanyuDepartment of Animal Biology and Conservation, University of Buea, P. O. Box 63, Buea, Cameroon.
Jessica BurnsDivision of Human Genetics and Molecular Biology, Stellenbosch University, Private Bag X1, Matieland, Stellenbosch 7602, South Africa.
Victor Bassey ArchibongDepartment of Human Anatomy, University of Rwanda, P. O. Box 4285, Kigali, Rwanda.
Rosa M ChinheyaDepartment of Pharmacology, University of the Free State, P. O. Box 339, Bloemfontein 9300, South Africa.
Nji S Ombel MusaDepartment of Animal Biology and Conservation, University of Buea, P. O. Box 63, Buea, Cameroon.
Shingirayi ZengeniDepartment of Pharmacy and Pharmaceutical Sciences, University of Zimbabwe, P. O. Box MP167, Mount Pleasant, Harare, Zimbabwe.
Asmaa Haj-KhlifaFaculty of Sciences Semlalia, Cadi Ayyad University, B. P. 511-4000 Marrakech, Morocco.
Kehinde Oluwaseyi AdenijiDepartment of Anatomy, Babcock University, 121003 Ilishan-Remo, Ogun, Nigeria.
Rhoda Mama KoloDepartment of Anatomy, University of Ilorin, 240003 Kwara, Ilorin South, Nigeria.
Mooki CarolineDSI/Preclinical Drug Development Platform, North-West University, Private Bag X6001, 2520 Potchefstroom, South Africa.
Fatma Zahra SakhriLaboratoire d' Obtention de Substances Therapeutiques, National Research Center of Biotechnology, UV 03, BP E73, 25000 Constantine, Algeria.
Elias ChipofyaDepartment of Biotechnology and Consumer Sciences, Cape Peninsula University of Technology, P. O. Box 1906, Bellville, 7535 Cape Town, South Africa.

Funding

International Brain Research Organization
6 · The paper itself

Abstract

Sub-Saharan Africa is experiencing a rising burden of neurological and mental disorders. The International Brain Research Organization (IBRO)-funded 2nd School on Neuropharmacology Research and Drug Development (NRDD) was held in Harare, Zimbabwe, 2024. The meeting aimed to (1) provide a theoretical foundation in neuropharmacology; (2) develop skills in experimental design, pharmacokinetics, and drug evaluation; (3) foster interdisciplinary collaboration and networking; and (4) promote cultural and scientific exchange. Thirteen participants from eight African countries attended the 1-week program. This Meeting Review evaluates the extent to which the meeting achieved its goals, drawing on structured reflections from all participants, and describes the scientific, networking, cultural, and logistical dimensions of the experience. The school successfully equipped participants with foundational knowledge in neuropharmacology and drug development. Future editions would benefit from extended hands-on sessions and structured post-program follow-up.

Indexed as

Drug DevelopmentNeuropharmacologyHumansZimbabweAfricaDrug discoveryIBROMedicinal plantsNeuropharmacologyResearch training

Identifiers

PMID42273748
PMCPMC13382971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.